The Las Vegas Strip records its third straight month of gaming win growth
Seeking Alpha News (Fri, 29-May 10:30 AM ET)
Business Wire (Thu, 21-May 8:00 AM ET)
Business Wire (Thu, 7-May 7:00 AM ET)
Business Wire (Mon, 4-May 8:00 AM ET)
Genius Sports Announces Close of Acquisition of Legend
Business Wire (Fri, 1-May 6:00 AM ET)
Genius Sports to Announce First Quarter 2026 Results on May 7
Business Wire (Thu, 23-Apr 8:00 AM ET)
Genius Sports Appoints Tony Marlow as Chief Marketing Officer
Business Wire (Thu, 9-Apr 8:00 AM ET)
Digital Advertising Leaders Unite Around Genius Sports' Moment Engine for Real-Time Activation
Business Wire (Thu, 26-Mar 8:00 AM ET)
PRNewswire (Tue, 24-Mar 3:21 PM ET)
Business Wire (Thu, 19-Mar 9:00 AM ET)
Genius Sports Ltd is a B2B provider of scalable, technology-led products and services to the sports, sports betting, and sports media industries. Its services are organized into three key product areas: Sports Technology and Services; Betting Technology, Content, and Services; and Media Technology, Content, and Services. All of its products are powered by proprietary technology and robust data infrastructure. It generates maximum revenue from the Betting Technology, Content, and Services division. Geographically, the company derives a majority of its revenue from America.
Genius Sports trades on the NYSE stock market under the symbol GENI.
As of June 1, 2026, GENI stock price climbed to $6.05 with 4,557,918 million shares trading.
GENI has a beta of 2.03, meaning it tends to be more sensitive to market movements. GENI has a correlation of 0.13 to the broad based SPY ETF.
GENI has a market cap of $1.62 billion. This is considered a Small Cap stock.
Last quarter Genius Sports reported $188 million in Revenue and -$.21 earnings per share. This beat revenue expectation by $18 million and missed earnings estimates by -$.20.
In the last 3 years, GENI traded as high as $13.73 and as low as $3.83.
The top ETF exchange traded funds that GENI belongs to (by Net Assets): IWM, ARKW, WCMI, IWO, VTWO.
GENI has underperformed the market in the last year with a return of -37.9%, while the SPY ETF gained +29.8%. In the last 3 month period, GENI fell short of the market, returning -2.6%, while SPY returned +10.8%. However, in the most recent 2 weeks GENI has outperformed the stock market by returning +42.7%, while SPY returned +2.6%.
GENI support price is $5.61 and resistance is $6.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GENI shares will trade within this expected range on the day.
